Abstract, Snapshot, Market Analysis & Market Definition: General Anesthesia Drugs Market
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.
In 2019, the market size of General Anesthesia Drugs is 6679.3 million US$ and it will reach 8070.6 million US$ in 2025, growing at a CAGR of 2.7% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for General Anesthesia Drugs. This report studies the global market size of General Anesthesia Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). This study presents the General Anesthesia Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
Market Segmentation, Outlook & Regional Insights: General Anesthesia Drugs Market
Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025:
Intravenous Anesthetics
Inhalational Anesthetics
Key Players, Recent Developments & Sector Viewpoints: General Anesthesia Drugs Market
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Key Insights Covered: Exhaustive General Anesthesia Drugs Market
1. Market size (sales, revenue and growth rate) of General Anesthesia Drugs industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate and gross margin) of General Anesthesia Drugs industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of General Anesthesia Drugs industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of General Anesthesia Drugs industry.
Research Methodology: General Anesthesia Drugs Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.